Castleberry Pharmaceutical Product Lawyer, Alabama


Jeffrey Trainham Brock

General Practice
Status:  In Good Standing           Licensed:  34 Years

Henry Lomax Cassady

Lawsuit & Dispute, Wills & Probate, Personal Injury, Professional Malpractice
Status:  In Good Standing           Licensed:  34 Years

Stanley Bernard Stallworth

Real Estate
Status:  In Good Standing           Licensed:  34 Years

Todd Brandon Watson

Government, Criminal
Status:  Inactive           Licensed:  25 Years

William Roy Farmer

General Practice
Status:  Inactive           Licensed:  33 Years

Max Cassady

Civil Rights, Civil & Human Rights
Status:  In Good Standing           

Greg Albritton

Criminal, Real Estate
Status:  In Good Standing           

Melissa L. Padgett

DUI-DWI, Divorce, Personal Injury, Family Law
Status:  In Good Standing           

Free Help: Use This Form or Call 800-620-0900

Member Representative

Call me for fastest results!
800-620-0900

Free Help: Use This Form or Call 800-620-0900

By submitting this lawyer request, I confirm I have read and agree to the Consent to Receive Messages from all messaging and voice technologies including Email, Text, Phone, Terms of Use, and Privacy Policy. Information provided is not privileged or confidential.


Free Help: Use This Form or Call 800-943-8690

Member Representative

Call me for fastest results!
800-943-8690

Free Help: Use This Form or Call 800-943-8690

By submitting this lawyer request, I confirm I have read and agree to the Consent to Receive Messages from all messaging and voice technologies including Email, Text, Phone, Terms of Use, and Privacy Policy. Information provided is not privileged or confidential.

TIPS

Easily find Castleberry Pharmaceutical Product Lawyers and Castleberry Pharmaceutical Product Law Firms. For more attorneys, search all Health Care areas including Medical Products & Devices, Medicare & Medicaid and Other Health Care attorneys.

SAMPLE LEGAL CASES

EX PARTE PAR PHARMACEUTICAL, INC.

... noted above in Novartis II, the State's second amended complaint sets forth the same basic allegations against the 73 pharmaceutical companies ... of its drugs "was priced and marketed in light of competitive pressures and other variables in each individual product market." (Par's ...

ASTRAZENECA LP v. State

... 10%—reduced the AWP. This formula is the product in large part of studies the AMA had conducted in 1985 and 1987 by two large pharmaceutical wholesalers of the average prices paid by pharmacies for prescription drugs. ...

Ex parte Novartis Pharmaceuticals Corp.

... The pharmaceutical manufacturers argue that this case "share[s] none of the characteristics with those in which this Court has[, in the past ... GSK's petition at 6. They argue that this Court has endorsed consolidation "in cases involving a single, identifiable product or event," such ...